CHAIN DRUG REVIEW holds 2 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 16 (Paper & Printed Goods) with 2 filings. The WikiTrademarks Expansion Score is 0/100, low — the brand is focused on defending its existing categories rather than expanding.
USPTO data refreshed July 18, 2026
Own this brand? Claim the profile to add your logo, story, and website.
Sign in to claimHow is CHAIN DRUG REVIEW filing trademarks, and where is the portfolio expanding?
Filing Velocity (24 Months)
Filing Activity by NICE Class
Nice Class Distribution
Activity Timeline
No activity recorded yet.
Recent Filings
| Serial No. | Mark | Filing Date | Status | Classes | Owner |
|---|---|---|---|---|---|
| 99554637 | CHAIN DRUG REVIEW | Dec 18, 2025 | Registered | 016 Paper & Printed Goods | Racher Press, Inc |
| 86728212 | CHAIN DRUG REVIEW | Aug 18, 2015 | Abandoned | 016 Paper & Printed Goods | Racher Press, Inc |
Weekly visibility reports showing how ChatGPT mentions CHAIN DRUG REVIEW, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.
FAQ: CHAIN DRUG REVIEW trademark portfolio
What trademarks does CHAIN DRUG REVIEW hold?
CHAIN DRUG REVIEW holds 2 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 16 (Paper & Printed Goods). The most recent filings are registered to Racher Press, Inc.
How many trademarks does CHAIN DRUG REVIEW have at the USPTO?
WikiTrademarks tracks 2 USPTO trademark filings attributed to CHAIN DRUG REVIEW. The brand has been actively filing since August 2015. The count updates daily as new filings are indexed from the USPTO bulk data feed.
In which NICE classes does CHAIN DRUG REVIEW file most often?
CHAIN DRUG REVIEW's most active class is NICE Class 16 (Paper & Printed Goods), with 2 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.
Who owns the CHAIN DRUG REVIEW trademark?
The most recent filings under the CHAIN DRUG REVIEW mark are registered to Racher Press, Inc. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.
Is CHAIN DRUG REVIEW expanding into new categories?
The current WikiTrademarks Expansion Score for CHAIN DRUG REVIEW is 0 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.
How can I track new CHAIN DRUG REVIEW trademark filings?
Click the Watch Brand button at the top of this page to add CHAIN DRUG REVIEW to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.
More on this portfolio: Compare CHAIN DRUG REVIEW to another owner · Browse all NICE classes · Most valuable brands
Community notes
0 notesShare what you know about CHAIN DRUG REVIEW and help the next person researching it.